Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1180.1000 12.40 (1.06%)
NSE Jan 14, 2026 15:31 PM
Volume: 726.3K
 

1180.10
1.06%
HDFC Securities
Aurobindo Pharma Ltd Q2FY19 results Comment Revenue grew by 11.61% to Rs. 4667.12 Cr in Q2FY19 when compared to the previous quarter. Also, it increased by 7.19% when compared with Q2FY18.
Aurobindo Pharma Ltd. is trading above its 200 day SMA of 1145.0
More from Aurobindo Pharma Ltd.
Recommended